Sinocelltech Group Ltd - Asset Resilience Ratio

Latest as of September 2025: 5.27%

Sinocelltech Group Ltd (688520) has an Asset Resilience Ratio of 5.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥198.05 Million

≈ $28.98 Million USD Cash + Short-term Investments

Total Assets

CN¥3.76 Billion

≈ $550.42 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Sinocelltech Group Ltd's Asset Resilience Ratio has changed over time. See 688520 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Sinocelltech Group Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sinocelltech Group Ltd (688520) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥198.05 Million	5.27%
Total Liquid Assets	CN¥198.05 Million	5.27%

Asset Resilience Insights

Limited Liquidity: Sinocelltech Group Ltd maintains only 5.27% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sinocelltech Group Ltd Industry Peers by Asset Resilience Ratio

Compare Sinocelltech Group Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	2.34%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	Biotechnology	39.07%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%

Annual Asset Resilience Ratio for Sinocelltech Group Ltd (None–None)

The table below shows the annual Asset Resilience Ratio data for Sinocelltech Group Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Sinocelltech Group Ltd

SHG:688520 China Biotechnology

Market Cap

$2.36 Billion

CN¥16.13 Billion CNY

Market Cap Rank

#5624 Global

#1041 in China

Share Price

CN¥36.22

Change (1 day)

+3.19%

52-Week Range

CN¥33.00 - CN¥73.20

All Time High

CN¥101.80